WebOct 29, 2024 · The company's revenue and earnings (over time) are depicted in the image below (click to see the exact numbers). NasdaqGS:CYCN Earnings and Revenue Growth October 29th 2024 WebApr 11, 2024 · Cyclerion Therapeutics stock was originally listed at a price of $12.50 in Mar 18, 2024. If you had invested in Cyclerion Therapeutics stock at $12.50, your return over the last 4 years would have been -95.68%, for an annualized return of -54.41% (not including any dividends or dividend reinvestments).
Cyclerion Therapeutics, Inc. (CYCN) Earnings Report
Web13 rows · Mar 31, 2024 · Cyclerion Therapeutics last issued its earnings results on March 22nd, 2024. The reported ($0.16) ... WebJul 26, 2024 · Cyclerion Therapeutics, Inc. (CYCN) delivered earnings and revenue surprises of 8.82% and 56.90%, respectively, for the quarter ended June 2024. Do the … facebook iveta laz
Cyclerion Therapeutics, Inc. (CYCN) - Yahoo Finance
WebMar 27, 2024 · Detailed statistics for Cyclerion Therapeutics, Inc. (CYCN) stock, including valuation metrics, financial numbers, share information and more. ... Estimated Earnings Date May 3, 2024: Ex-Dividend Date n/a: Share Statistics. CYCN has 43.52 million shares outstanding. The number of shares has increased by 11.05% in one year. WebMar 22, 2024 · CAMBRIDGE, Mass., March 22, 2024 — Cyclerion Therapeutics, Inc. (Nasdaq: CYCN) today announced corporate updates including advances in its zagociguat (formerly CY6463) mitochondrial disease program. The Company previously reported clinical data in adult patients with MELAS* that indicate that zagociguat may have … WebMar 31, 2024 · When is the next earnings date for Cyclerion TherapeuticsInc.? Click to get the best stock tips daily for free! TSLA $207.46 6.24% MULN $0.131 8.96% CLLXF $3.15 7.14% NVDA $277.77 1.44% AAPL $164.90 1.56% AMZN $103.29 1.26% SPY $409.39 1.41% QQQ $320.93 1.66% MSFT $288.30 1.50% AI $33.57 21.50% About Cyclerion … facebook isabella ilz